Literature DB >> 22559057

Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.

Anne Arens1, Jens-Uwe Appelt, Cynthia C Bartholomae, Richard Gabriel, Anna Paruzynski, Derek Gustafson, Nathalie Cartier, Patrick Aubourg, Annette Deichmann, Hanno Glimm, Christof von Kalle, Manfred Schmidt.   

Abstract

Clonality analysis of viral vector-transduced cell populations represents a convincing approach to dissect the physiology of tissue and organ regeneration, to monitor the fate of individual gene-corrected cells in vivo, and to assess vector biosafety. With the decoding of mammalian genomes and the introduction of next-generation sequencing technologies, the demand for automated bioinformatic analysis tools that can rapidly process and annotate vector integration sites is rising. Here, we provide a publicly accessible, graphical user interface-guided automated bioinformatic high-throughput integration site analysis pipeline. Its performance and key features are illustrated on pyrosequenced linear amplification-mediated PCR products derived from one patient previously enrolled in the first lentiviral vector clinical gene therapy study. Analysis includes trimming of vector genome junctions, alignment of genomic sequence fragments to the host genome for the identification of integration sites, and the annotation of nearby genomic elements. Most importantly, clinically relevant features comprise the determination of identical integration sites with respect to different time points or cell lineages, as well as the retrieval of the most prominent cell clones and common integration sites. The resulting output is summarized in tables within a convenient spreadsheet and can be further processed by researchers without profound bioinformatic knowledge.

Entities:  

Mesh:

Year:  2012        PMID: 22559057      PMCID: PMC4015219          DOI: 10.1089/hgtb.2011.219

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  49 in total

1.  The return of clonal marking sheds new light on human hematopoietic stem cells.

Authors:  I R Lemischka; C T Jordan
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

2.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

Review 3.  Is normal hematopoiesis maintained solely by long-term multipotent stem cells?

Authors:  Marina Cavazzana-Calvo; Alain Fischer; Frederic D Bushman; Emmanuel Payen; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

4.  An unbiased genome-wide analysis of zinc-finger nuclease specificity.

Authors:  Richard Gabriel; Angelo Lombardo; Anne Arens; Jeffrey C Miller; Pietro Genovese; Christine Kaeppel; Ali Nowrouzi; Cynthia C Bartholomae; Jianbin Wang; Geoffrey Friedman; Michael C Holmes; Philip D Gregory; Hanno Glimm; Manfred Schmidt; Luigi Naldini; Christof von Kalle
Journal:  Nat Biotechnol       Date:  2011-08-07       Impact factor: 54.908

5.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Authors:  Marina Cavazzana-Calvo; Emmanuel Payen; Olivier Negre; Gary Wang; Kathleen Hehir; Floriane Fusil; Julian Down; Maria Denaro; Troy Brady; Karen Westerman; Resy Cavallesco; Beatrix Gillet-Legrand; Laure Caccavelli; Riccardo Sgarra; Leila Maouche-Chrétien; Françoise Bernaudin; Robert Girot; Ronald Dorazio; Geert-Jan Mulder; Axel Polack; Arthur Bank; Jean Soulier; Jérôme Larghero; Nabil Kabbara; Bruno Dalle; Bernard Gourmel; Gérard Socie; Stany Chrétien; Nathalie Cartier; Patrick Aubourg; Alain Fischer; Kenneth Cornetta; Frédéric Galacteros; Yves Beuzard; Eliane Gluckman; Frederick Bushman; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962

6.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Authors:  Marion G Ott; Manfred Schmidt; Kerstin Schwarzwaelder; Stefan Stein; Ulrich Siler; Ulrike Koehl; Hanno Glimm; Klaus Kühlcke; Andrea Schilz; Hana Kunkel; Sonja Naundorf; Andrea Brinkmann; Annette Deichmann; Marlene Fischer; Claudia Ball; Ingo Pilz; Cynthia Dunbar; Yang Du; Nancy A Jenkins; Neal G Copeland; Ursula Lüthi; Moustapha Hassan; Adrian J Thrasher; Dieter Hoelzer; Christof von Kalle; Reinhard Seger; Manuel Grez
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

7.  New genes involved in cancer identified by retroviral tagging.

Authors:  Takeshi Suzuki; Haifa Shen; Keiko Akagi; Herbert C Morse; James D Malley; Daniel Q Naiman; Nancy A Jenkins; Neal G Copeland
Journal:  Nat Genet       Date:  2002-08-19       Impact factor: 38.330

8.  Restoration of NET formation by gene therapy in CGD controls aspergillosis.

Authors:  Matteo Bianchi; Abdul Hakkim; Volker Brinkmann; Ulrich Siler; Reinhard A Seger; Arturo Zychlinsky; Janine Reichenbach
Journal:  Blood       Date:  2009-06-18       Impact factor: 22.113

9.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

10.  Identifying viral integration sites using SeqMap 2.0.

Authors:  Troy B Hawkins; Jessica Dantzer; Brandon Peters; Mary Dinauer; Keithanne Mockaitis; Sean Mooney; Kenneth Cornetta
Journal:  Bioinformatics       Date:  2011-01-17       Impact factor: 6.937

View more
  30 in total

1.  Cell cycle status of CD34(+) hemopoietic stem cells determines lentiviral integration in actively transcribed and development-related genes.

Authors:  Eleni Papanikolaou; Anna Paruzynski; Ioannis Kasampalidis; Annette Deichmann; Evangelos Stamateris; Manfred Schmidt; Christof von Kalle; Nicholas P Anagnou
Journal:  Mol Ther       Date:  2014-12-19       Impact factor: 11.454

2.  Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease.

Authors:  Ngoc B Lu-Nguyen; Martin Broadstock; Maximilian G Schliesser; Cynthia C Bartholomae; Christof von Kalle; Manfred Schmidt; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther       Date:  2014-04-15       Impact factor: 5.695

3.  Linear amplification mediated PCR--localization of genetic elements and characterization of unknown flanking DNA.

Authors:  Richard Gabriel; Ina Kutschera; Cynthia C Bartholomae; Christof von Kalle; Manfred Schmidt
Journal:  J Vis Exp       Date:  2014-06-25       Impact factor: 1.355

4.  Vector integration and tumorigenesis.

Authors:  Christof von Kalle; Annette Deichmann; Manfred Schmidt
Journal:  Hum Gene Ther       Date:  2014-06       Impact factor: 5.695

5.  TALEN-based gene correction for epidermolysis bullosa.

Authors:  Mark J Osborn; Colby G Starker; Amber N McElroy; Beau R Webber; Megan J Riddle; Lily Xia; Anthony P DeFeo; Richard Gabriel; Manfred Schmidt; Christof von Kalle; Daniel F Carlson; Morgan L Maeder; J Keith Joung; John E Wagner; Daniel F Voytas; Bruce R Blazar; Jakub Tolar
Journal:  Mol Ther       Date:  2013-04-02       Impact factor: 11.454

6.  Fanconi anemia gene editing by the CRISPR/Cas9 system.

Authors:  Mark J Osborn; Richard Gabriel; Beau R Webber; Anthony P DeFeo; Amber N McElroy; Jordan Jarjour; Colby G Starker; John E Wagner; J Keith Joung; Daniel F Voytas; Christof von Kalle; Manfred Schmidt; Bruce R Blazar; Jakub Tolar
Journal:  Hum Gene Ther       Date:  2015-02       Impact factor: 5.695

7.  Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles.

Authors:  Kaifeng Shao; Carmen Koch; Manoj K Gupta; Qiong Lin; Michael Lenz; Stephanie Laufs; Bernd Denecke; Manfred Schmidt; Matthias Linke; Hans C Hennies; Jürgen Hescheler; Martin Zenke; Ulrich Zechner; Tomo Šarić; Wolfgang Wagner
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

8.  Efficiency and safety of O⁶-methylguanine DNA methyltransferase (MGMT(P140K))-mediated in vivo selection in a humanized mouse model.

Authors:  Ruhi Phaltane; Reinhard Haemmerle; Michael Rothe; Ute Modlich; Thomas Moritz
Journal:  Hum Gene Ther       Date:  2014-01-07       Impact factor: 5.695

9.  CEP290 gene transfer rescues Leber congenital amaurosis cellular phenotype.

Authors:  E R Burnight; L A Wiley; A V Drack; T A Braun; K R Anfinson; E E Kaalberg; J A Halder; L M Affatigato; R F Mullins; E M Stone; B A Tucker
Journal:  Gene Ther       Date:  2014-05-08       Impact factor: 5.250

10.  Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases.

Authors:  Mark J Osborn; Beau R Webber; Friederike Knipping; Cara-lin Lonetree; Nicole Tennis; Anthony P DeFeo; Amber N McElroy; Colby G Starker; Catherine Lee; Sarah Merkel; Troy C Lund; Karen S Kelly-Spratt; Michael C Jensen; Daniel F Voytas; Christof von Kalle; Manfred Schmidt; Richard Gabriel; Keli L Hippen; Jeffrey S Miller; Andrew M Scharenberg; Jakub Tolar; Bruce R Blazar
Journal:  Mol Ther       Date:  2015-10-27       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.